Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advance Solid Tumors”

33 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 33 results

Early research (Phase 1)Study completedNCT00503204
What this trial is testing

Phase I : Cediranib in Combination With Lomustine Chemotherapy in Recurrent Malignant Brain Tumour

Who this might be right for
Recurrent GlioblastomaBrain Tumor
AstraZeneca 20
Not applicableLooking for participantsNCT06795815
What this trial is testing

The Implementation of the Go Wish Game to Promote Advance Care Planning in Onco- Hematologic Disease

Who this might be right for
LeukemiaMultiple MielomaAdvanced Solid Tumors+3 more
Azienda USL Reggio Emilia - IRCCS 75
Early research (Phase 1)Ended earlyNCT01137552
What this trial is testing

Dose Escalation Study of AMG 780 in Adult Subjects With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Amgen 44
Early research (Phase 1)Study completedNCT02301117
What this trial is testing

A Phase I Study of TAS-102 in Patients With Advanced Solid Tumors With Renal Impairment

Who this might be right for
Advanced Solid Tumors
Taiho Oncology, Inc. 43
Early research (Phase 1)Looking for participantsNCT05238792
What this trial is testing

Multi Tumor-Associated Antigen-Specific T Lymphocytes to Treat Patients with High Risk Solid Tumors

Who this might be right for
Solid Tumor
Children's National Research Institute 36
Testing effectiveness (Phase 2)Looking for participantsNCT04262466
What this trial is testing

Safety and Efficacy of IMC-F106C as a Single Agent and in Combination With Checkpoint Inhibitors

Who this might be right for
Select Advanced Solid Tumors
Immunocore Ltd 727
Early research (Phase 1)Ended earlyNCT05621525
What this trial is testing

Phase I Study of the BBP-398 in Patients With Advance Solid Tumors

Who this might be right for
Advanced Solid TumorAdvanced or Metastatic Non-small Cell Lung Cancer
LianBio LLC 7
Early research (Phase 1)Study completedNCT04850755
What this trial is testing

A Phase I Dose Escalation Study of Selinexor Plus Nivolumab and Ipilimumab in Advanced/Metastatic Solid Malignancies

Who this might be right for
Advance Solid MalignanciesMetastatic Solid Malignancies
National University Hospital, Singapore 11
Early research (Phase 1)Study completedNCT00426140
What this trial is testing

Pharmacokinetics of Patupilone After a Single Intravenous Administration in Patients With Advance Solid Tumor Malignancies.

Who this might be right for
Advanced MalignanciesSolid Tumors
Novartis Pharmaceuticals 5
Testing effectiveness (Phase 2)Looking for participantsNCT06249048
What this trial is testing

Phase 1/2 Study of Intratumoral Injection of STX-001 in Advanced Solid Tumors as Monotherapy or in Combination With Pembrolizumab

Who this might be right for
Advanced Solid Tumor
Strand Therapeutics Inc. 108
Not applicableStudy completedNCT01817686
What this trial is testing

Study of Default Options in Advance Directives

Who this might be right for
COPDSevere or Very Severe Airflow Obstruction and/or Receiving or Eligible to Receive Long-term Oxygen TherapyIdiopathic Pulmonary Fibrosis+5 more
Corporal Michael J. Crescenz VA Medical Center 62
Not applicableLooking for participantsNCT04515810
What this trial is testing

Mobile Health Application (PACT) to Improve Engagement in Advance Care Planning

Who this might be right for
Malignant Solid Neoplasm
Fred Hutchinson Cancer Center 400
Testing effectiveness (Phase 2)Study completedNCT03037385
What this trial is testing

Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid Tumors

Who this might be right for
RET-altered Non Small Cell Lung CancerMedullary Thyroid CancerRET-altered Papillary Thyroid Cancer+37 more
Hoffmann-La Roche 590
Not applicableLooking for participantsNCT07174661
What this trial is testing

Educational Tools for the Improvement of Early Advance Care Planning in Adolescents and Young Adults With Advanced Solid Tumors and High-Grade Brain Tumors

Who this might be right for
Advanced Malignant Solid NeoplasmMalignant Brain NeoplasmRecurrent Advanced Malignant Solid Neoplasm
Mayo Clinic 50
Testing effectiveness (Phase 2)Study completedNCT05161390
What this trial is testing

Study of LM-302 in Patients With Advance Solid Tumors

Who this might be right for
Advanced Solid Tumor
LaNova Medicines Zhejiang Co., Ltd. 153
Not applicableNot Yet RecruitingNCT07141407
What this trial is testing

Telephone-Based Coaching Sessions (TAC) to Improve Advance Care Planning Participation in Advanced Cancer Patients and Their Support Person

Who this might be right for
Advanced Malignant Solid NeoplasmHematopoietic and Lymphatic System Neoplasm
Fred Hutchinson Cancer Center 80
Testing effectiveness (Phase 2)Ended earlyNCT05008445
What this trial is testing

Study of LM-102 in Patients With Advance Solid Tumors

Who this might be right for
Advanced Solid Tumor
LaNova Medicines Development Co., Ltd. 11
Testing effectiveness (Phase 2)Active Not RecruitingNCT04557449
What this trial is testing

Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors

Who this might be right for
LiposarcomaProstate CancerBreast Neoplasms+1 more
Pfizer 362
Early research (Phase 1)Study completedNCT05001516
What this trial is testing

Study of Turning Point Therapeutics LM-302 in Patients With Advance Solid Tumors

Who this might be right for
Advanced Solid Tumor
Turning Point Therapeutics, Inc. 17
Testing effectiveness (Phase 2)Study completedNCT03035591
What this trial is testing

ODM-207 in Patients With Advance Solid Tumours

Who this might be right for
Solid Tumors
Orion Corporation, Orion Pharma 36
Load More Results